Literature DB >> 17073743

STAT3-mediated anti-inflammatory signalling.

P J Murray1.   

Abstract

IL-1O (interleukin-10) negatively regulates inflammation through a mechanism that blocks the expression of pro-inflammatory genes encoding cytokines, chemokines, cell-surface molecules and other molecules required for the full activation of the innate and adaptive immune responses. The signalling pathway used by the IL-10 receptor to generate the anti-inflammatory response requires STAT3 (signal transducer and activator of transcription 3) and is indirect. Thus STAT3 activates other genes whose task is to selectively control transcription of inflammatory targets. Here, I summarize current knowledge of the key features of IL-10 signalling and make predictions concerning the mechanism of IL-10 at the level of inflammatory genes. Understanding IL-10 signalling should be a gateway to the development of broadly acting anti-inflammatory agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073743     DOI: 10.1042/BST0341028

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  53 in total

1.  IL-10 inhibits miR-155 induction by toll-like receptors.

Authors:  Claire E McCoy; Frederick J Sheedy; Joseph E Qualls; Sarah L Doyle; Susan R Quinn; Peter J Murray; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

2.  New Approaches for Studying Alcoholic Liver Disease.

Authors:  Jun Xu; Xiao Liu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2014-09-14

3.  Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms.

Authors:  Farah Kako; Khatuna Gabunia; Mitali Ray; Sheri E Kelemen; Ross N England; Bashar Kako; Rosario G Scalia; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

4.  Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.

Authors:  Ying Tian; Laura J Sommerville; Anthony Cuneo; Sheri E Kelemen; Michael V Autieri
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

Review 5.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

Review 6.  Leishmania interferes with host cell signaling to devise a survival strategy.

Authors:  Suvercha Bhardwaj; Neetu Srivastava; Raki Sudan; Bhaskar Saha
Journal:  J Biomed Biotechnol       Date:  2010-04-08

7.  Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.

Authors:  Malgorzata Romanowska; Louise Reilly; Colin N A Palmer; Mattias C U Gustafsson; John Foerster
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

8.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

9.  Transcriptional control of cytokine release from monocytes of the newborn: effects of endogenous and exogenous interleukin-10 versus dexamethasone.

Authors:  Lina A Chusid; Lucy Pereira-Argenziano; Veronika Miskolci; Ivana Vancurova; Dennis Davidson
Journal:  Neonatology       Date:  2009-08-28       Impact factor: 4.035

10.  The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10.

Authors:  Susan R Quinn; Niamh E Mangan; Brian E Caffrey; Michael P Gantier; Bryan R G Williams; Paul J Hertzog; Claire E McCoy; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.